BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 30697147)

  • 1. Cannabinoid Ligands Targeting TRP Channels.
    Muller C; Morales P; Reggio PH
    Front Mol Neurosci; 2018; 11():487. PubMed ID: 30697147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in
    Oakes M; Law WJ; Komuniecki R
    J Neurosci; 2019 May; 39(21):4142-4152. PubMed ID: 30886012
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.
    De Petrocellis L; Orlando P; Moriello AS; Aviello G; Stott C; Izzo AA; Di Marzo V
    Acta Physiol (Oxf); 2012 Feb; 204(2):255-66. PubMed ID: 21726418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors.
    Muller C; Reggio PH
    Front Cell Neurosci; 2020; 14():615811. PubMed ID: 33362478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terpenoids Commonly Found in
    Heblinski M; Santiago M; Fletcher C; Stuart J; Connor M; McGregor IS; Arnold JC
    Cannabis Cannabinoid Res; 2020; 5(4):305-317. PubMed ID: 33376801
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma membrane stretch activates transient receptor potential vanilloid and ankyrin channels in Merkel cells from hamster buccal mucosa.
    Soya M; Sato M; Sobhan U; Tsumura M; Ichinohe T; Tazaki M; Shibukawa Y
    Cell Calcium; 2014 Apr; 55(4):208-18. PubMed ID: 24642224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of transient receptor potential ankyrin 1 (TRPA1) by the TRP vanilloid 1-selective cannabinoid arachidonoyl-2 chloroethanolamine.
    Ruparel NB; Patwardhan AM; Akopian AN; Hargreaves KM
    Mol Pharmacol; 2011 Jul; 80(1):117-23. PubMed ID: 21441412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure Δ
    Romano B; Pagano E; Orlando P; Capasso R; Cascio MG; Pertwee R; Marzo VD; Izzo AA; Borrelli F
    Pharmacol Res; 2016 Nov; 113(Pt A):199-208. PubMed ID: 27498155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRP channels and analgesia.
    Premkumar LS; Abooj M
    Life Sci; 2013 Mar; 92(8-9):415-24. PubMed ID: 22910182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of cannabidiol by transient receptor potential channels.
    Etemad L; Karimi G; Alavi MS; Roohbakhsh A
    Life Sci; 2022 Jul; 300():120582. PubMed ID: 35483477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling.
    Storozhuk MV; Zholos AV
    Curr Neuropharmacol; 2018 Jan; 16(2):137-150. PubMed ID: 28440188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
    De Petrocellis L; Vellani V; Schiano-Moriello A; Marini P; Magherini PC; Orlando P; Di Marzo V
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1007-15. PubMed ID: 18354058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.
    Borrelli F; Pagano E; Romano B; Panzera S; Maiello F; Coppola D; De Petrocellis L; Buono L; Orlando P; Izzo AA
    Carcinogenesis; 2014 Dec; 35(12):2787-97. PubMed ID: 25269802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting temperature-sensitive transient receptor potential channels in hypertension: far beyond the perception of hot and cold.
    Jesus RLC; Araujo FA; Alves QL; Dourado KC; Silva DF
    J Hypertens; 2023 Sep; 41(9):1351-1370. PubMed ID: 37334542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.
    Akopian AN; Ruparel NB; Jeske NA; Patwardhan A; Hargreaves KM
    Trends Pharmacol Sci; 2009 Feb; 30(2):79-84. PubMed ID: 19070372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells.
    Wilhelmsen K; Khakpour S; Tran A; Sheehan K; Schumacher M; Xu F; Hellman J
    J Biol Chem; 2014 May; 289(19):13079-100. PubMed ID: 24644287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
    Ma S; G G; Ak VE; Jf D; H H
    Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions and Regulation of Ionotropic Cannabinoid Receptors.
    De Petrocellis L; Nabissi M; Santoni G; Ligresti A
    Adv Pharmacol; 2017; 80():249-289. PubMed ID: 28826537
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.